More than 50% of market pros think a vaccine will be ready within a year

To Know more how you can benefit from the Muslim Times, go to our Homepage or About Us page

Covid 19 vaccine

The Muslim Times has the best collection of articles for the war against Covid 19, especially the vaccines.

Source: Yahoo

‘Optimism on a vaccine has increased notably.’

Positive news surrounding the development of a vaccine for COVID-19 continues.

On Monday, The Lancet published promising results of a COVID-19 vaccine study by the University of Oxford and AstraZenaca. Pfizer and BioNTech also reported positive early data from their own COVID-19 vaccine study on Monday.

The market’s reaction to the news was muted, though a massive rally in tech stocks dragged all three major indexes to gains to start the week.

And the results of a recent survey from Deutsche Bank perhaps explain why investors did not take this news as a meaningful new catalyst for the market. Seeing these headlines instead as the kind of interim vaccine news that has increasingly been priced into stocks over the last few weeks.

In its latest monthly sentiment survey of 500 market professionals from around the globe, Deutsche Bank found that some 56% of respondents believe a vaccine will be available within a year.

Read further

The best of the Muslim Times’ collection for war against Covid 19:

In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.

For the latest news about drugs and vaccines’ trials please go to: Pharmaceutical-Technology

For the latest health news from BBC, Please click here

Novavax starting human trial of its vaccine in Australia

Kaiser Permanente launches first coronavirus vaccine trial

Corona Fear’s Cure: Chanting from the Bible and the Quran

Can You Chant from the Bible or the Quran to Bliss and Happiness?

Japanese flu drug ‘clearly effective’ in treating coronavirus, says China

Synthetic antibodies might offer a quick coronavirus treatment

The Four Possible Timelines for Life Returning to Normal

The Muslim Times Recommending Universal BCG Vaccination to Fight the Pandemic

Coronavirus: TB Vaccination Trial Started in Melbourne, Australia

The Muslim Times has the best collections in the war against Covid 19 as we are collecting from all the established sources

All of humanity are intimate neighbors: Coronavirus proves it once again

Praise be to God for the Miracle of Our Immune System

USA: 15-minute coronavirus test is here

Does the Ordinary Soap Kill Coronavirus?

Here’s a list of disinfectants you can use against coronavirus

For the number of cases and epidemiology in each country go to: WorldOMeters


Categories: The Muslim Times, Vaccine

1 reply

  1. Pfizer Vaccine Deal at $20 a Dose Sets Ceiling for Rivals

    In signing a $2 billion deal to supply their experimental coronavirus vaccine to the U.S., Pfizer Inc. and BioNTech SE are setting a price ceiling of less than $20 a dose that will impact how much other companies can charge to protect people from Covid-19.

    Pfizer’s $19.50 price-point takes into account the “public health requirements during the pandemic,” said Sally Beatty, a Pfizer spokeswoman. The companies are pursuing a two-dose regimen of one of its vaccine candidates, and the roughly $40 course, Beatty said, is “almost 30% less than what others charge for a seasonal flu vaccine.”

Leave a Reply